Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05100654 · ClinicalTrials.gov registry record · Early Phase 1
Collaborative Urological Prosthetics Investigation Directive Research Group
A Early Phase 1 study of Erectile Dysfunction and Penile Prosthesis Infection, sponsored by University of Chicago.
- Active
- Registry status
- Early Phase 1
- Development phase
- 800
- Enrollment target
- 1
- Study location
NCT05100654 is a Early Phase 1 study of Erectile Dysfunction and Penile Prosthesis Infection that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 800 participants, above the 207-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (286% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05100654, a Early Phase 1 study of Erectile Dysfunction and Penile Prosthesis Infection, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if an additional 6 days of oral antibiotics decreases the risk of penile prosthesis infection after implantation.
Conditions Studied
Interventions
- DRUG Ciprofloxacin
- DRUG Doxycycline
- DRUG Augmentin
- DRUG Bactrim
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2022-04-22 |
| Est. Completion | 2028-01-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05100654
The ClinicalTrials.gov registry entry for NCT05100654 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 207-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (286% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 4 interventions - of which Ciprofloxacin is the first listed.
NCT05100654 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05100654 about?
NCT05100654 is a clinical study titled "Collaborative Urological Prosthetics Investigation Directive Research Group". The purpose of this study is to determine if an additional 6 days of oral antibiotics decreases the risk of penile prosthesis infection after implantation.
What is the current status of trial NCT05100654?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 800 participants. The study started on 2022-04-22. Estimated completion is 2028-01-01.
What conditions does trial NCT05100654 study?
This clinical trial studies the following conditions: Erectile Dysfunction, Penile Prosthesis Infection.
What interventions are being tested in trial NCT05100654?
The interventions under investigation include: Ciprofloxacin (DRUG), Doxycycline (DRUG), Augmentin (DRUG), Bactrim (DRUG).
Who is sponsoring clinical trial NCT05100654?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05100654 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
RECRUITING · Phase 3
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.